FDA Inspection
Coastal Bend Blood CenterCoastal Bend Blood Center – FDA Inspection, Jul 14, 2017
Record Details
This FDA Inspection record concerns Coastal Bend Blood Center, with an inspection on July 14, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ef658eff-852c-4ae5-a85e-90486bf39ec2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1018250
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.60(b)Equipment calibration frequency
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Coastal Bend Blood Center
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 28, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 13, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 17, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 12, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 15, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Coastal Bend Blood Center
- FDA Inspection 1266889 - 2025-03-28
- FDA Inspection 1097872 - 2019-06-13
- FDA Inspection 930894 - 2015-06-17
- FDA Inspection 829012 - 2013-04-12
- FDA Inspection 730447 - 2011-06-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.